UNCY
Unicycive Therapeutics Inc

3,106
Mkt Cap
$142.49M
Volume
398,971.00
52W High
$11.00
52W Low
$3.71
PE Ratio
-2.04
UNCY Fundamentals
Price
$6.31
Prev Close
$6.63
Open
$6.51
50D MA
$6.67
Beta
0.82
Avg. Volume
518,136.03
EPS (Annual)
-$5.65
P/B
3.69
Rev/Employee
$0.00
$27.83
Loading...
Loading...
News
all
press releases
Unicycive Therapeutics (UNCY) to Release Quarterly Earnings on Monday
Unicycive Therapeutics (NASDAQ:UNCY) will be releasing earnings before the market opens on Monday, March 30. (View Earnings Report at...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Unicycive Therapeutics (NASDAQ:UNCY) Shares Down 0.4% - Here's Why
Unicycive Therapeutics (NASDAQ:UNCY) Trading Down 0.4% - Should You Sell...
MarketBeat·15d ago
News Placeholder
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the five brokerages that are currently covering the firm...
MarketBeat·1mo ago
News Placeholder
Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Up 2.4% - Should You Buy?
Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Up 2.4% - Still a Buy...
MarketBeat·1mo ago
News Placeholder
Analysts Set Expectations for UNCY FY2030 Earnings
Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Analysts at HC Wainwright issued their FY2030 earnings per share estimates for Unicycive Therapeutics in a research report issued on Monday...
MarketBeat·2mo ago
News Placeholder
Unicycive Resubmits NDA For Oxylanthanum Carbonate To FDA
(RTTNews) - Unicycive Therapeutics, Inc. (UNCY) on Monday said it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration for oxylanthanum carbonate (OLC) for the...
Nasdaq News: Markets·3mo ago
News Placeholder
Vivo Capital LLC Has $5.42 Million Stock Position in Unicycive Therapeutics, Inc. $UNCY
Vivo Capital LLC lowered its position in shares of Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) by 90.0% in the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·4mo ago
News Placeholder
Unicycive Therapeutics (NASDAQ:UNCY) Trading Up 5.6% - Time to Buy?
Unicycive Therapeutics (NASDAQ:UNCY) Trading 5.6% Higher - Time to Buy...
MarketBeat·4mo ago
News Placeholder
UNCY FY2025 EPS Boosted by Brookline Capital Management
Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Research analysts at Brookline Capital Management boosted their FY2025 EPS estimates for Unicycive Therapeutics in a research report issued...
MarketBeat·4mo ago
News Placeholder
HC Wainwright Has Positive Outlook for UNCY FY2029 Earnings
Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Research analysts at HC Wainwright boosted their FY2029 EPS estimates for Unicycive Therapeutics in a research note issued to investors on...
MarketBeat·4mo ago
<
1
2
...
>

Latest UNCY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.